Epidemiology, outcomes, and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy
D Neofytos, K Lu, A Hatfield-Seung, A Blackford… - … and infectious disease, 2013 - Elsevier
This is a retrospective, single-center study of adult patients with newly diagnosed acute
myelogenous leukemia (AML), who received intensive induction timed sequential …
myelogenous leukemia (AML), who received intensive induction timed sequential …
Breakthrough invasive fungal infections in patients with acute myeloid leukemia
A Wasylyshyn, KA Linder, CG Castillo, S Zhou… - Mycopathologia, 2020 - Springer
Objectives We sought to determine the occurrence, risk factors, effect of antifungal
prophylaxis, and outcomes of invasive fungal infections (IFIs) in patients with acute myeloid …
prophylaxis, and outcomes of invasive fungal infections (IFIs) in patients with acute myeloid …
High incidences of invasive fungal infections in acute myeloid leukemia patients receiving induction chemotherapy without systemic antifungal prophylaxis: a …
JL Tang, HC Kung, WC Lei, M Yao, UI Wu, SC Hsu… - PloS one, 2015 - journals.plos.org
Invasive fungal infections (IFIs) is an important complication for acute myeloid leukemia
(AML) patients receiving induction chemotherapy. However, the epidemiological information …
(AML) patients receiving induction chemotherapy. However, the epidemiological information …
Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: a retrospective cohort study
This study investigated the epidemiology and risk factors associated with invasive fungal
infections (IFIs) during induction chemotherapy in a cohort of Taiwanese patients with newly …
infections (IFIs) during induction chemotherapy in a cohort of Taiwanese patients with newly …
Invasive fungal infections in acute leukemia
VR Bhatt, GM Viola, A Ferrajoli - Therapeutic advances in …, 2011 - journals.sagepub.com
Invasive fungal infection (IFI) is among the leading causes for morbidity, mortality, and
economic burden for patients with acute leukemia. In the past few decades, the incidence of …
economic burden for patients with acute leukemia. In the past few decades, the incidence of …
Risk factors for breakthrough invasive fungal infection during secondary prophylaxis
OA Cornely, A Böhme, D Reichert… - Journal of …, 2008 - academic.oup.com
Background Intensive chemotherapy with severe neutropenia is associated with invasive
fungal infections (IFIs) leading to high mortality rates. During leukaemia induction …
fungal infections (IFIs) leading to high mortality rates. During leukaemia induction …
Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis
R Rodríguez-Veiga, P Montesinos, B Boluda… - Annals of …, 2019 - Springer
Few reports analyze the incidence and clinical outcome of invasive fungal disease (IFD) in
patients with newly diagnosed acute myeloid leukemia (AML) undergoing intensive …
patients with newly diagnosed acute myeloid leukemia (AML) undergoing intensive …
How we treat invasive fungal diseases in patients with acute leukemia: the importance of an individualized approach
M Nucci, E Anaissie - Blood, The Journal of the American …, 2014 - ashpublications.org
Invasive fungal diseases (IFDs) represent an important cause of treatment failure in adults
with acute leukemia. Because of leukemia's heterogeneity, the risk for IFDs is highly …
with acute leukemia. Because of leukemia's heterogeneity, the risk for IFDs is highly …
Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China
Y Sun, H Huang, J Chen, J Li, J Ma, J Li, Y Liang… - Tumor Biology, 2015 - Springer
This stud y examined the epidemiology, risk factors, management, and outcome of invasive
fungal infection (IFI) in patients receiving chemotherapy for hematological malignancy in …
fungal infection (IFI) in patients receiving chemotherapy for hematological malignancy in …
Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center …
Although primary antifungal prophylaxis (PAP) is routinely administered in patients with
acute myeloid leukemia (AML) during remission-induction and consolidation chemotherapy …
acute myeloid leukemia (AML) during remission-induction and consolidation chemotherapy …